1. |
Bartlett JG. Antibiotic-associated diarrhea[J]. N Engl J Med, 2002, 346(5):334-339.
|
2. |
Mcfarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea[J]. Digest Dis, 1998, 16(5):292-307.
|
3. |
Yin X, Song FJ, Gong YH, et al. A systematic review of antibiotic utilization in China[J]. J Antimicrob Chemother, 2013, 68(11):2445-2452.
|
4. |
Currie J, Lin WC, Zhang W. Patient knowledge and antibiotic abuse:evidence from an audit study in China[J]. J Health Econ, 2011, 30(5):933-949.
|
5. |
Levy J. The effects of antibiotic use on gastrointestinal function[J]. Am J Gastroenterol, 2000, 95(Suppl 1):S8-S10.
|
6. |
Salminen S. Human studies on probiotics:aspects of scientific documentation[J]. Scand J Nutr, 2001, 45(1):8-12.
|
7. |
Cremonini F, Di Caro S, Santarelli L, et al. Probiotics in antibiotic-associated diarrhoea[J]. Dig Liver Dis, 2002, 34(Suppl 2):S78-S80.
|
8. |
Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health[J]. J Nutr, 2000, 130(Suppl 2):396S-402S.
|
9. |
Gratz SW, Mykkanen H, El-Nezami HS. Probiotics and gut health:a special focus on liver diseases[J]. World J Gastroenterol, 2010, 16(4):403-410.
|
10. |
Johnston BC, Goldenberg JZ, Vandvik PO, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea[J]. Cochrane Database Syst Rev, 2011(11):CD004827.
|
11. |
Avadhani A, Miley H. Probiotics for prevention of antibiotic-associated diarrhea and clostridium difficile-associated disease in hospitalized adults. A meta-analysis[J]. J Am Acad Nurse Pract, 2011, 23(6):269-274.
|
12. |
Hickson M, D'souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics:randomised double blind placebo controlled trial[J]. BMJ, 2007, 335(7610):80-83.
|
13. |
Beausoleil M, Fortier N, Guénette S, et al. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea:a randomized, double-blind, placebo-controlled trial[J]. Can J Gastroenterol, 2007, 21(11):732-736.
|
14. |
Allen SJ, Wareham K, Wang D, et al. A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital:a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE)[J]. Health Technol Assess, 2013, 17(57):1-140.
|
15. |
Wright K, Wright H, Murray M. Probiotic treatment for the prevention of antibiotic-associated diarrhoea in geriatric patients:a multicentre randomised controlled pilot study[J/OL]. Australas J Ageing, 2014. doi:10.1111/ajag.12116.
|
16. |
Pozzoni P, Riva A, Bellatorre AG, et al. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients:a single-center, randomized, double-blind, placebo-controlled trial[J]. Am J Gastroenterol, 2012, 107(6):922-931.
|
17. |
Hartling L, Ospina M, Liang YY, et al. Risk of bias versus quality assessment of randomised controlled trials:cross sectional study[J]. BMJ, 2009, 339:b4012.
|
18. |
Lewis SJ, Potts LF, Barry RE. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients[J]. J Infect, 1998, 36(2):171-174.
|
19. |
Plummer S, Weaver MA, Harris JC, et al. Clostridium difficile pilot study:effects of probiotic supplementation on the incidence of C. difficile diarrhoea[J]. Int Microbiol, 2004, 7(1):59-62.
|
20. |
Safdar N, Barigala R, Said A, et al. Feasibility and tolerability of probiotics for prevention of antibiotic-associated diarrhoea in hospitalized US military veterans[J]. J Clin Pharm Ther, 2008, 33(6):663-668.
|
21. |
Hébuterne X. Gut changes attributed to ageing:effects on intestinal microflora[J]. Curr Opin Clin Nutr Metab Care, 2003, 6(1):49-54.
|
22. |
Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles[J]. Gut, 2001, 48(2):198-205.
|
23. |
Hopkins MJ, Macfarlane GT. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection[J]. J Med Microbiol, 2002, 51(5):448-454.
|
24. |
McFarland LV. Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients[J]. Am J Infect Control, 1995, 23(5):295-305.
|
25. |
Johnston BC, Goldenberg JZ, Vandvik PO, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea[J]. Cochrane Database Syst Rev, 2007(2):CD004827.
|
26. |
Szajewska H, Ruszczyński M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children:a meta-analysis of randomized controlled trials[J]. J Pediatr, 2006, 149(3):367-372.
|
27. |
Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea:a systematic review and meta-analysis[J]. JAMA, 2012, 307(18):1959-1969.
|